Release date: 2010-09-03
Christian Kandlbauer lost his arms in a high-voltage accident, and his unique developments have until recently sounded almost like science fiction: the world's first similar arm prosthesis, which he controlled alone through his brain power.
Otto Bock proposed the first prototype of a mind-controlled prosthesis in 2008. Now, the company has launched the first mind-controlled prosthesis for everyday use. The unique development of the Christian Kandlbauer on the left side greatly enhances his independence and confidence, so that he can not only work in his original career, but he can also drive to his workplace independently.
Otto Bock collaborates with US research partners to leverage the expertise of the Targeted Muscle Reinnervation (TMR) from the Rehabilitation Institute of Chicago, Dr. Todd Kuiken, and from Vienna Experts at the General Hospital (Vienna's General Hospital) have teamed up to apply TMR to patients. This involves transferring the remaining nerves to the chest muscles, giving the brain a signal to control the prosthesis. As the project leader Dr. Hubert Egger emphasized, the weight of the natural arm dropped to 2.5 kg, and its appearance is essential for use in daily life.
Future prospects With the help of laboratory conditions and microsensors integrated into the index finger, Christian Kandlbauer can feel the same as before the accident. However, this wonderful further development will take some time to perfect. Dr. Hans Dietl, CEO of Otto Bock HealthCare's Vienna Products Division, is expected to bring sensor arm prosthetics to the market in about four years.
Source: PR Newswire
Respiratory disease is a common disease, frequently-occurring disease, the main lesion in the trachea, bronchi, lung and chest, lesions are more cough, chest pain, respiratory effects, severe breathing difficulties, hypoxia, and even respiratory failure and death. Due to air pollution, smoking and other factors, The chronic obstructive pulmonary disease is increasing including chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, lung cancer, pulmonary diffuse interstitial fibrosis, and pulmonary infection the morbidity and mortality of the disease at home and abroad . Therefore, Anti-Respiratory disease drugs are also more and more attention paid by researchers. Respiratory disease have the symptoms of cough, sputum, hemoptysis, chest pain, shortness of breath and other symptoms of lack of specificity, often clinicians mistaken by people for colds, bronchitis, and severe pneumonia, tuberculosis or lung cancer and other diseases delayed diagnosis; Respiratory tract infection, to be developed to emphysema, pulmonary heart disease, respiratory failure was taken seriously, but it was too late, its pathology and physiological function has been difficult to reverse. As with other systemic diseases, careful and detailed medical history and physical examination are the basis for the diagnosis of respiratory diseases, and should be combined with routine laboratory tests and other special findings to conduct a comprehensive and comprehensive analysis. Currently the most clinical application of anti-respiratory disease drugs have the following four categories: 1. Antihistamines 2. Cough medicine 3. Bronchodilator 4. Expectorant 5. Anti-asthma Drugs.
Anti-Respiratory
Anti-asthma Drugs, Antitussives, Expectorants, β adrenergic receptor agonists, M Cholinergic Blockers, Phosphodiesterase Inhibitors, Anti-Respiratory Drugs,Respiratory System Diseases Treatment
Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com